Skip to content

Oric Pharmaceuticals

US · ORIC #3089 by market cap Listed 2020
7.36 -0.34 -4.42%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Oric Pharmaceuticals

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Founded
2014
CEO
Mr. Jacob M. Chacko, M.B.A.,M.D.
Employees
104
Headquarters
South San Francisco, California, United States of America
Fiscal year end
12-31
Website
oricpharma.com

Company profile

Exchange
US
Symbol
ORIC
Market-cap rank
#3089
Listing date
2020-04-24
Market cap
764.94M
Float cap
704.32M
Shares out
103.93M
Float shares
95.70M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Oric Pharmaceuticals discussion 0 comments

Add a comment